Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr 11:14:1192190.
doi: 10.3389/fimmu.2023.1192190. eCollection 2023.

Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume I

Xiang-Jie Di  1   2 , Qi Zhao  3 , Hai-Tao Wang  4 , Xia-Wei Wei  2 , Xiao Liang  1
Affiliations
Editorial

Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume I

Xiang-Jie Di et al. Front Immunol. .
No abstract available

Keywords: exosomes; immunotherapy; non-tumor cells targeting; ovarian cancer; tumor immune microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume I

References

    1. Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ, Bast RC, Jr., Beral V, et al. . Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer (2015) 15:668–79. doi: 10.1038/nrc4019 - DOI - PMC - PubMed
    1. Dalmartello M, La Vecchia C, Bertuccio P, Boffetta P, Levi F, Negri E, et al. . European Cancer mortality predictions for the year 2022 with focus on ovarian cancer. Ann Oncol (2022) 33:330–9. doi: 10.1016/j.annonc.2021.12.007 - DOI - PubMed
    1. Odunsi K. Immunotherapy in ovarian cancer. Ann Oncol (2017) 28:viii1–7. doi: 10.1093/annonc/mdx444 - DOI - PMC - PubMed
    1. Bejarano L, Jordāo MJC, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discovery (2021) 11:933–59. doi: 10.1158/2159-8290.CD-20-1808 - DOI - PubMed
    1. Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther (2021) 221:107753. doi: 10.1016/j.pharmthera.2020.107753 - DOI - PMC - PubMed

Publication types